LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency

Autor: O’Connor, Marie N., Kallenberg, David M., Camilli, Carlotta, Pilotti, Camilla, Dritsoula, Athina, Jackstadt, Rene, Bowers, Chantelle E., Watson, H. Angharad, Alatsatianos, Markella, Ohme, Julia, Dowsett, Laura, George, Jestin, Blackburn, Jack W.D., Wang, Xiaomeng, Singhal, Mahak, Augustin, Hellmut G., Ager, Ann, Sansom, Owen J., Moss, Stephen E., Greenwood, John

Publikováno v: In Med 12 November 2021 2(11):1231-1252

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Role for ATF2 in Regulating MITF and Melanoma Development.

Autor: Shah, Meera, Bhoumik, Anindita, Goel, Vikas, Dewing, Antimone, Breitwieser, Wolfgang, Kluger, Harriet, Krajewski, Stan, Krajewska, Maryla, DeHart, Jason, Lau, Eric, Kallenberg, David M., Hyeongnam Jeong, Eroshkin, Alexey, Bennett, Dorothy C., Chin, Lynda, Bosenberg, Marcus, Jones, Nic, Ronai, Ze'ev A.

Publikováno v: PLoS Pathogens; Feb2011, Vol. 7 Issue 2, Special section p1-21, 21p, 2 Color Photographs, 4 Charts, 5 Graphs

LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency.

Autor: O'Connor MN; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Kallenberg DM; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Camilli C; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Pilotti C; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Dritsoula A; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Jackstadt R; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Bowers CE; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Watson HA; Division of Infection and Immunity, School of Medicine and Systems Immunity University Research Institute, Cardiff University, Cardiff CF14 4XN, UK., Alatsatianos M; Division of Infection and Immunity, School of Medicine and Systems Immunity University Research Institute, Cardiff University, Cardiff CF14 4XN, UK., Ohme J; Division of Infection and Immunity, School of Medicine and Systems Immunity University Research Institute, Cardiff University, Cardiff CF14 4XN, UK., Dowsett L; Institute of Ophthalmology, University College London, London SE5 8BN, UK., George J; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Blackburn JWD; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Wang X; Institute of Ophthalmology, University College London, London SE5 8BN, UK., Singhal M; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany; Department of Vascular Biology and Tumor Angiogenesis, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Augustin HG; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany; Department of Vascular Biology and Tumor Angiogenesis, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Ager A; Division of Infection and Immunity, School of Medicine and Systems Immunity University Research Institute, Cardiff University, Cardiff CF14 4XN, UK., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Moss SE; Institute of Ophthalmology, University College London, London SE5 8BN, UK. Electronic address: s.moss@ucl.ac.uk., Greenwood J; Institute of Ophthalmology, University College London, London SE5 8BN, UK. Electronic address: j.greenwood@ucl.ac.uk.

Publikováno v: Med (New York, N.Y.) [Med] 2021 Nov 12; Vol. 2 (11), pp. 1231-1252.e10. Date of Electronic Publication: 2021 Nov 03.